Johnson & Johnson (JNJ)
153.47
-0.89 (-0.58%)
At close: Apr 15, 2025, 3:59 PM
153.75
0.18%
After-hours: Apr 15, 2025, 07:59 PM EDT
Johnson & Johnson Revenue Breakdown
| Period Ending | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Oct 1, 2023 | Oct 3, 2010 | Jul 4, 2010 |
|---|---|---|---|---|---|---|---|
| MedTech Revenue | 7.89B | 7.96B | 7.82B | 7.67B | 7.46B | 5.92B | 6.13B |
| MedTech Revenue Growth | -0.83% | +1.74% | +1.93% | +2.88% | +25.98% | -3.43% | n/a |
| INNOVATIVE MEDICINE Revenue | 14.58B | 14.49B | 13.56B | 13.72B | 13.89B | n/a | n/a |
| INNOVATIVE MEDICINE Revenue Growth | +0.62% | +6.84% | -1.17% | -1.23% | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Jan 1, 2023 | Jan 2, 2022 | Jan 3, 2021 | Dec 29, 2019 | Dec 30, 2018 | Dec 31, 2017 | Jan 1, 2017 | Jan 3, 2016 | Dec 28, 2014 | Dec 29, 2013 | Dec 30, 2012 | Jan 1, 2012 | Jan 2, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia-Pacific, Africa Revenue | 13.76B | 16.79B | 17.27B | 15.14B | 15.55B | 14.83B | 13.42B | 12.57B | 12.35B | 13.44B | 13.38B | 16.95B | 17.13B | 11.08B |
| Asia-Pacific, Africa Revenue Growth | -18.07% | -2.81% | +14.13% | -2.69% | +4.88% | +10.51% | +6.72% | +1.85% | -8.15% | +0.45% | -21.03% | -1.07% | +54.64% | n/a |
| Europe Revenue | 20.41B | 23.45B | 23.59B | 18.98B | 18.47B | 18.75B | 17.13B | 15.77B | 15.99B | 18.95B | 18.6B | 29.83B | 28.91B | 15.51B |
| Europe Revenue Growth | -12.96% | -0.61% | +24.31% | +2.78% | -1.53% | +9.50% | +8.60% | -1.41% | -15.58% | +1.87% | -37.65% | +3.19% | +86.38% | n/a |
| United States Revenue | 46.44B | 48.58B | 47.16B | 43.13B | 42.1B | 41.88B | 39.86B | 37.81B | 35.69B | 34.78B | 31.91B | n/a | n/a | 29.45B |
| United States Revenue Growth | -4.40% | +3.02% | +9.33% | +2.46% | +0.51% | +5.07% | +5.43% | +5.95% | +2.60% | +9.00% | n/a | n/a | n/a | n/a |
| Western Hemisphere, Excluding U.S. Revenue | 4.55B | 6.13B | 5.75B | 5.33B | 5.94B | 6.11B | 6.04B | 5.73B | 6.04B | 7.16B | 7.42B | n/a | n/a | n/a |
| Western Hemisphere, Excluding U.S. Revenue Growth | -25.73% | +6.52% | +7.78% | -10.20% | -2.81% | +1.19% | +5.35% | -5.14% | -15.57% | -3.52% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 29, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Oct 1, 2023 | Jul 2, 2023 | Apr 2, 2023 | Jan 1, 2023 | Oct 2, 2022 | Jul 3, 2022 | Apr 3, 2022 | Jan 2, 2022 | Oct 3, 2021 | Jul 4, 2021 | Apr 4, 2021 | Jan 3, 2021 | Sep 27, 2020 | Jun 28, 2020 | Mar 29, 2020 | Dec 29, 2019 | Sep 29, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 30, 2018 | Sep 30, 2018 | Jul 1, 2018 | Apr 1, 2018 | Dec 31, 2017 | Oct 1, 2017 | Jul 2, 2017 | Apr 2, 2017 | Jan 1, 2017 | Oct 2, 2016 | Jul 3, 2016 | Apr 3, 2016 | Jan 3, 2016 | Sep 27, 2015 | Jun 28, 2015 | Mar 29, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 6.25B | 5.28B | 5.48B | 5.06B | 5.51B | 5.1B | 5B | 4.51B | 6.51B | 4.97B | 6.23B | 5.64B | 7.15B | 6B | 6.07B | 5.43B | 6.46B | 5.43B | 4.99B | 5.2B | 6.04B | 5.37B | 5.55B | 5.22B | 5.99B | 5.54B | 5.74B | 5.26B | 6.03B | 5.42B | 5.29B | 4.76B | 5.31B | 4.77B | 5.18B | 4.69B | 5.89B | 5.08B | 5.38B | 4.85B |
| Selling, General, and Administrative Revenue Growth | +18.47% | -3.70% | +8.38% | -8.22% | +8.04% | +2.08% | +10.87% | -30.80% | +30.89% | -20.09% | +10.43% | -21.19% | +19.23% | -1.20% | +11.80% | -15.87% | +18.89% | +8.77% | -4.04% | -13.84% | +12.37% | -3.10% | +6.27% | -12.89% | +8.08% | -3.48% | +9.12% | -12.65% | +11.10% | +2.53% | +11.04% | -10.28% | +11.25% | -7.81% | +10.41% | -20.42% | +15.94% | -5.63% | +11.08% | n/a |
| Research and Development Revenue | 5.3B | 4.95B | 3.44B | 3.54B | 4.48B | 3.45B | 3.7B | 3.46B | 4.62B | 3.48B | 3.7B | 4.07B | 4.72B | 3.42B | 3.39B | 3.18B | 4.03B | 2.84B | 2.71B | 2.58B | 3.23B | 2.6B | 2.67B | 2.86B | 3.22B | 2.51B | 2.64B | 2.4B | 3.63B | 2.58B | 2.3B | 2.07B | 2.64B | 2.18B | 2.26B | 2.01B | 2.86B | 2.15B | 2.13B | 1.9B |
| Research and Development Revenue Growth | +6.99% | +43.95% | -2.88% | -20.94% | +29.97% | -6.91% | +7.18% | -25.28% | +32.68% | -5.89% | -9.06% | -13.73% | +37.93% | +0.82% | +6.80% | -21.18% | +41.97% | +4.91% | +4.92% | -20.17% | +24.36% | -2.51% | -6.72% | -11.35% | +28.55% | -4.96% | +9.78% | -33.87% | +40.62% | +12.59% | +10.92% | -21.59% | +21.21% | -3.80% | +12.47% | -29.71% | +32.96% | +1.17% | +12.11% | n/a |